Effects of lipid nanocarriers on the performance of topical vehicles in vivo

Journal of Cosmetic Dermatology

Volumn 8, Issue 2, 2009, Pages 136-143

  Moddaresi, Mojgan ^a,b   Tamburic, Slobodanka ^a   Williams, Stefanie ^a   Jones, Stuart A ^b   Zhao, Yanjun ^b   Brown, Marc B ^c,d  

^a LONDON COLLEGE OF FASHION   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^d MEDPHARM LTD   (United Kingdom)

Author keywords

Antioxidant efficacy; Lipid nanocarriers; Skin hydration; Skin viscoelasticity; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; DRUG VEHICLE; LIPID NANOCARRIER; NANOCARRIER; NICOTINIC ACID METHYL ESTER; PLACEBO; SILICONE OIL; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ARTICLE; BIOMECHANICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEOMETRY; CUTANEOUS PARAMETERS; CUTOMETRY; DRUG DOSAGE FORM COMPARISON; DRUG EXPOSURE; DRUG FORMULATION; FOAM; GEL; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN HYDRATION; SKIN REDNESS; SPECTROPHOTOMETRY; ULTRACENTRIFUGATION; VISCOELASTICITY;

ADMINISTRATION, CUTANEOUS; ADULT; ALGORITHMS; ANTIOXIDANTS; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NANOSPHERES; NICOTINIC ACIDS; PRACTICE GUIDELINES AS TOPIC; SILICONE OILS; SINGLE-BLIND METHOD; SKIN; SKIN IRRITANCY TESTS; SPECTROPHOTOMETRY; TOCOPHEROLS; VEHICLES;

EID: 66949137826     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00440.x     Document Type: Article

References (25)

1. Souto EB, Muller RH. Challenging cosmetics - solid lipid nanoparticles (SLN®) and nanostructured lipid carriers (NLC®). In: JW Wiechers, ed. Science and Application of Skin Delivery Systems. Carol Stream: Allured Publication; 2008: 225-50.
2. Muller RH, Dingler A. The next generation after the liposomes: Solid lipid nanoparticles (SLN®, Lipopearls®) as dermal carrier in cosmetics. Eurocosmetics 1998; 7/8: 19-26.
3. Souto EB, Muller RH. Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®). Int J Cosmet Sci 2008; 30: 157-65.
4. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54: S131-55.
5. Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002; 19: 875-80.
6. Alberts DS, Goldman R, Xu MJ, Dorr RT, Quinn J, Welch K, GuillenRodriguez J, Aickin M, Peng YM, Loescher L, Gensler H. Disposition and metabolism of topically administered alpha-tocopherol acetate: A common ingredient of commercially available sunscreens and cosmetics. Nutr Cancer 1996; 26: 193-201.
7. Packer L, Valacchi G. Antioxidants and the response of skin to oxidative stress: Vitamin E as a key indicator. Skin Physiol Pharmacol 2002; 15: 282-90.
8. Panin G, Strumia R, Ursini F. Topical tocopherol acetate in the bulk phase: Eight years of experience in skin treatment. Ann NY Acad Sci 2004; 1031: 443-7.
9. Barry BW. Structure, function, disease and topical treatment of human skin. In: BW Barry, ed. Dermatological Formulations: Percutaneous Absorption. New York: Marcel Dekker; 1983: 1-48.
10. Tavakkol A, Nabi Z, Soliman N, Polefka TG. Delivery of vitamin E to the skin by a novel liquid skin cleanser: Comparison of topical versus oral supplementation. J Cosmet Sci 2004; 55: 177-87.
11. Dingler A, Blum RP, Niehus H, Muller RH, Gohla S. Solid lipid nanoparticles (SLN™/Lipopearls™) a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsul 1999; 16: 751-67.
12. Ranjgarajan M, Zatz JL. Kinetics of permeation and metabolism of alpha tocopherol and alpha tocopherol acetate in micro-Yuctan pig skin. J Cosmet Sci 2001; 52: 155-61.
13. Baschong W, Artmann C, Hueglin D, Roeding J. Direct evidence for bioconversion of vitamin E acetate into vitamin E: An ex vivo studying viable human skin. J Cosmet Sci 2001; 5: 155-61.
14. Brown MB, Marriott C, Martin GP. A study of the transdermal drug delivery properties of hyaluronan. In: DA Willoughby, ed. Hyaluronan in Drug Delivery. London: Royal Society of Medicine Press; 1995: 53-71.
15. Vertuani S, Ziosi P, Solaroli N, Buzzoni V, Carli M, Lucchi E, Valgimigli L, Baratto G, Manfredini S. Determination of antioxidant efficacy of cosmetic formulations by non-invasive measurements. Skin Res Technol 2003; 9: 245-53.
16. Berardesca E. EEMCO guidance for the assessment of stratum corneum hydration: Electrical methods. Skin Res Technol 1997; 3: 126-32.
17. Barel AO, Courage W, Clarys P. Suction method for measurement of skin mechanical properties: The cutometer. In: J Serup, GBE Jemec eds. Handbook of Non-invasive Methods and the Skin. Boca Raton, FL: CRC Press; 1995: 335-40.
18. Wilhelm KP, Maibach HI. Skin color reflectance measurement for objective quantification of erythema in human beings. J Am Acad Dermatol 1998; 21: 1306-8.
19. Brown MB, Jones SA. Hyaluronic acid: A unique topical vehicle for the localised delivery of drugs to the skin. JEADV 2004; 19: 308-18.
20. Wissing SA, Lippacher A, Muller HR. Investigations on the occlusive properties of solid lipid nanoparticles (SLN ™). J Cosmet Sci 2001; 52: 313-23.
21. Esposito E, Drechsler M, Mariani P, Sivieri E, Bozzini R, Montesi S, Menegatti E, Cortesi R. Nanosystems for skin hydration: A comparative study. Int J Cosmet Sci 2007; 29: 39-47.
22. Wissing SA, Muller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. Eur J Pharm Biopharm 2003; 56: 67-72.
23. Lambers H, Pronk H. Biophysical methods for stratum corneum characterisation. In: T Forster, ed. Cosmetic Lipids and the Skin Barrier. Boca Raton, FL: CRC Press; 2002: 185-225.
24. Bragt P, Bonta I. Oxidant stress during inflammation. Inflamm Res 2005; 10: 536-9.
25. Khodr B, Khalil Z. Modulation of inflammation by reactive oxygen species: Implications for ageing and tissue repair. Free Radic Biol Med 2001; 30: 1-8.